论文信息 - Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma - 字舞流文

Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma

W. Oyen | J. Langenhuijsen | W. Leenders | C. V. van Herpen | E. Oosterwijk | P. Mulders | O. Boerman | I. Desar | M. D. de Weijert | A. Stillebroer | M. Boers-Sonderen | C. Muselaers | Constantijn H. J. Muselaers